Back to Gliclazide Tablet

Gliclazide Tablet Side Effects in Pakistan

This guide covers Gliclazide Tablet (Gliclazide) for this formulation. Confirm the exact local label and individual prescription.

Compiled by the PakVita Editorial Team · AI-assisted drafting with editorial review · Sourced from DRAP, WHO, BNF · Last updated: · Review date on file:

A named review is not recorded for this page. Confirm medicine advice with your doctor or pharmacist.

The latest editorial changes have not received a new named clinical review.

Side Effects

Quick Answer

Reported effects of Gliclazide Tablet include Hypoglycaemia; Weight gain. Severe hypoglycaemia — unconsciousness, seizures (elderly, renal impairment, fasting); Haematological effects: thrombocytopenia, leukopenia (rare) require medical assessment. Lists do not establish how frequently an effect occurs.

Side Effects at a Glance

Reported effects

  • Hypoglycaemia
  • Weight gain
  • Nausea
  • Diarrhea
  • Headache

Reactions needing medical advice

  • Severe hypoglycaemia — unconsciousness, seizures (elderly, renal impairment, fasting)
  • Haematological effects: thrombocytopenia, leukopenia (rare)
  • Hepatotoxicity: jaundice, elevated liver enzymes (rare)

When to See a Doctor Immediately

  • Severe hypoglycaemia — unconsciousness, seizures (elderly, renal impairment, fasting)
  • Haematological effects: thrombocytopenia, leukopenia (rare)
  • Hepatotoxicity: jaundice, elevated liver enzymes (rare)

Gliclazide Tablet side effects

Reported Effects (Nuksanat)

  • Hypoglycaemia
  • Weight gain
  • Nausea
  • Diarrhea
  • Headache

Serious Effects and Warning Symptoms (Ahm alamat)

  • Severe hypoglycaemia — unconsciousness, seizures (elderly, renal impairment, fasting)
  • Haematological effects: thrombocytopenia, leukopenia (rare)
  • Hepatotoxicity: jaundice, elevated liver enzymes (rare)

A list does not determine frequency or prove causation. Seek medical advice for persistent, worsening or unexpected symptoms.

Interactions (Dawaon ke sath reaction)

NSAIDs/aspirin (enhance hypoglycaemia); beta-blockers (mask symptoms); fluconazole/miconazole (enhance hypoglycaemia); alcohol (enhanced hypoglycaemia); rifampicin (reduces efficacy)

Before Changing Treatment (Ilaj badalne se pehle)

  • Low blood sugar can cause sweating, shaking or confusion. If awake and able to swallow, follow the advised fast-acting carbohydrate treatment.
  • If unconscious, fitting or unable to swallow, do not give food or drink; call emergency services.
  • Risk of prolonged low blood sugar is higher with missed meals and kidney or liver disease.
  • A clinician should plan treatment before Ramadan fasting.
  • Beta-blockers can mask some low-blood-sugar symptoms.

Related Information (Mazeed maloomat)

Full Gliclazide Tablet guide · Uses · Dosage · Side effects

Educational information only. This editorial correction does not constitute a new clinician review. Confirm the local product leaflet and prescription with a qualified healthcare professional.

Frequently Asked Questions

Gliclazide Tablet kis kaam aati hai?

Gliclazide Tablet contains Gliclazide. Type 2 Diabetes Mellitus. The diagnosis and exact product determine suitability.

Dose kaise confirm karein?

The dose depends on whether the tablet is standard-release (such as 80 mg) or modified-release (30 mg or 60 mg). Follow the exact formulation’s prescription; do not exchange strengths tablet-for-tablet.

Bachon ke liye dose kya hai?

Not recommended in children — adult-onset Type 2 diabetes medicine

Pakistan mein price kitni hai?

A current price matched to the local strength and pack size has not been verified. Confirm the printed price, pack and expiry with a licensed pharmacy.

Nuksanat hon to kya karein?

Reported effects include Hypoglycaemia; Weight gain; Nausea. Seek medical help for Severe hypoglycaemia — unconsciousness, seizures (elderly, renal impairment, fasting); Haematological effects: thrombocytopenia, leukopenia (rare). A symptom list does not predict how often an effect occurs.

Explore entries related to Gliclazide Tablet by ingredient, class and listed uses. These links are not recommendations to switch treatment.

Sources

  1. Gliclazide — NHS
  2. DRAP Registered Product Data (Public Registry) — Drug Regulatory Authority of Pakistan
  3. WHO Model List of Essential Medicines, 23rd ed. (2023) — World Health Organization
  4. British National Formulary (BNF) — BMJ Group & Pharmaceutical Press

Medical disclaimer

This page is for educational use only and does not replace professional medical advice. Always confirm diagnosis, dose, and interactions with a qualified doctor or pharmacist before starting or changing any medicine.